Home | European Respiratory Society

COPD is associated with an increased risk of peripheral artery disease and mortality
Individuals with COPD have an almost doubled risk of developing peripheral arterial disease (PAD). People suffering from both COPD and PAD have substantially higher mortality rates.
Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma
There is a need for improved management of patients with severe persistent asthma to achieve better disease control
Systematic review of content and quality of idiopathic pulmonary fibrosis review articles
Recommendations for the diagnosis and management of IPF differ between North America and Europe and review articles frequently make recommendations for management of IPF that are discordant from international guidelines despite increased quality over time
Retrospective validation of a new volumetric capnography parameter for the exclusion of pulmonary embolism at the emergency department
Retrospective validation in a large multicentre dataset shows that a novel volumetric capnography derived parameter (CapNoPE) is decreased in patients with PE but its diagnostic accuracy seems too low to use in clinical practice
Sarcoidosis: patient treatment priorities
Sarcoidosis patient survey reveals QoL and functionality are required as core outcomes in treatment and care, along with more multidisciplinary working by clinicians and the establishment of specialist sarcoidosis centres in every European country

Latest Articles

COPD is associated with an increased risk of peripheral artery disease and mortality
Natalie Terzikhan, Lies Lahousse, Katia M.C. Verhamme, Oscar H. Franco, Arfan M. Ikram, Bruno H. Stricker, Guy G. Brusselle

ERJ Open Research Oct 2018, 4 (4) 00086-2018; DOI: 10.1183/23120541.00086-2018
Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma
Paraskevi Katsaounou, Mikaela Odemyr, Otto Spranger, Michael E. Hyland, Claus Kroegel, Lorena Garcia Conde, Robin Gore, Francesco Menzella, Christian Domingo Ribas, Mario Morais-Almeida, Matthias Gasser, Ismail Kasujee

ERJ Open Research Oct 2018, 4 (4) 00076-2018; DOI: 10.1183/23120541.00076-2018
Systematic review of content and quality of idiopathic pulmonary fibrosis review articles
Kathryn M. Milne, Chrystal Chan, Jolene H. Fisher, Kaīssa de Boer, Christopher J. Ryerson

ERJ Open Research Oct 2018, 4 (4) 00156-2018; DOI: 10.1183/23120541.00156-2018
“The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites” Elena K. Schneider, Rachel M. McQuade, Vincenzo C. Carbone, Felisa Reyes-Ortega, John W. Wilson, Brenda Button, Ayame Saito, Daniel P. Poole, Daniel Hoyer, Jian Li and Tony Velkov. ERJ Open Res 2018; 4: 00127-2017.
ERJ Open Research Oct 2018, 4 (4) 00127-2017-ERR; DOI: 10.1183/23120541.50127-2017
Retrospective validation of a new volumetric capnography parameter for the exclusion of pulmonary embolism at the emergency department
Timon M. Fabius, Michiel M.M. Eijsvogel, Marjolein G.J. Brusse-Keizer, Olivier M. Sanchez, Franck Verschuren, Frans H.C. de Jongh

ERJ Open Research Oct 2018, 4 (4) 00099-2018; DOI: 10.1183/23120541.00099-2018
Sarcoidosis: patient treatment priorities
Robert P. Baughman, Rita Barriuso, Kelli Beyer, Jeanette Boyd, Johann Hochreiter, Chris Knoet, Filippo Martone, Bernd Quadder, Jack Richardson, Ginger Spitzer, Dominique Valeyre, Gianluca Ziosi

ERJ Open Research Oct 2018, 4 (4) 00141-2018; DOI: 10.1183/23120541.00141-2018